George W. Lloyd

Insider Reports History

Location
New York, NY
Signature
/s/ Sean Weisberg, as Attorney-in-Fact for George W. Lloyd
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by George W. Lloyd:

Company Role Class Num Shares Value Price $ Report Date Ownership
Royalty Pharma plc EVP, Investments & CLO LP interests in RPI US Partners 2019, LP 291,739 $104,559,257 $358.40 06 Aug 2025 By GWL 2014 G, LLC
Royalty Pharma plc EVP, Investments & CLO LP interests in RPI US Partners 2019, LP 272,672 $97,725,644 $358.40 06 Aug 2025 By GWL 2020 G, LLC
Royalty Pharma plc EVP, Investments & CLO LP interests in RPI US Partners 2019, LP 130,148 $46,645,043 $358.40 06 Aug 2025 By GWL 2021 G LLC
Royalty Pharma plc EVP, Investments & CLO LP interests in RPI US Partners 2019, LP 58,173 $20,849,203 $358.40 06 Aug 2025 By GWL 2013 NG, LLC
Royalty Pharma plc EVP, Investments & CLO Class A Ordinary Shares 495,860 $19,606,304 $39.54 17 Dec 2025 By GWL 2013 NG, LLC
Royalty Pharma plc EVP, Investments & CLO Class A Ordinary Shares 273,960 $10,832,378 $39.54 17 Dec 2025 By IRA
Royalty Pharma plc EVP, Investments & CLO Class A Ordinary Shares 6,084 $240,561 $39.54 17 Dec 2025 By GWL 2023 G HoldCo LLC
Royalty Pharma plc EVP, Investments & CLO Class A Ordinary Shares 4,011 $158,602 $39.54 17 Dec 2025 By Spouse
Royalty Pharma plc EVP, Investments & CLO Class A Ordinary Shares 0 $0 $38.50 18 Dec 2025 By GWL 2014 G, LLC
Royalty Pharma plc EVP, Investments & CLO LP interests in RPI US Partners 2019, LP 0 $0 $358.40 08 Aug 2025 Direct
Royalty Pharma plc EVP, Investments & CLO Class E Ordinary Shares 1,944,471 16 May 2025 Indirect

Insider Reports Filed by George W. Lloyd

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RPRX Royalty Pharma plc 17 Dec 2025 2 -$4,240,333 4 EVP, Investments & CLO 19 Dec 2025, 17:24
RPRX Royalty Pharma plc 03 Dec 2025 1 -$4,375,008 4 EVP, Investments & CLO 05 Dec 2025, 17:01
RPRX Royalty Pharma plc 19 Nov 2025 8 -$5,192,656 4 EVP, Investments & CLO 21 Nov 2025, 16:55
RPRX Royalty Pharma plc 05 Nov 2025 1 $0 4 EVP, Investments & CLO 07 Nov 2025, 16:18
RPRX Royalty Pharma plc 06 Aug 2025 2 $0 4 EVP, Investments & CLO 08 Aug 2025, 16:56
RPRX Royalty Pharma plc 16 May 2025 1 $0 4 EVP, Investments & CLO 20 May 2025, 16:51
RPRX Royalty Pharma plc 08 May 2025 1 $0 4 EVP, Investments & CLO 09 May 2025, 17:15
RPRX Royalty Pharma plc 12 Aug 2024 1 $0 4 EVP, Investments & CLO 12 Aug 2024, 19:19
RPRX Royalty Pharma plc 13 Nov 2023 4 $0 4 EVP, Investments & CLO 14 Nov 2023, 19:35
RPRX Royalty Pharma plc 08 Aug 2023 1 $0 4 EVP, Investments & CLO 08 Aug 2023, 17:36
RPRX Royalty Pharma plc 02 Jun 2023 4 -$6,478,587 4 EVP, Investments & CLO 06 Jun 2023, 17:07
RPRX Royalty Pharma plc 28 Mar 2023 2 -$4,179,295 4 EVP, Investments & CLO 30 Mar 2023, 17:52
RPRX Royalty Pharma plc 23 Feb 2023 1 -$931,658 4 EVP, Investments & CLO 27 Feb 2023, 18:14
RPRX Royalty Pharma plc 21 Nov 2022 4 -$1,725,567 4 EVP, Investments & CLO 22 Nov 2022, 16:29
RPRX Royalty Pharma plc 10 Nov 2022 3 -$2,192,612 4 EVP, Investments & CLO 14 Nov 2022, 16:13
RPRX Royalty Pharma plc 09 Aug 2022 2 -$915,909 4 EVP, Investments & GC 11 Aug 2022, 17:02
RPRX Royalty Pharma plc 28 Jul 2022 1 -$177,893 4 EVP, Investments & GC 01 Aug 2022, 17:01
RPRX Royalty Pharma plc 25 Jul 2022 6 -$3,248,199 4 EVP, Investments & GC 27 Jul 2022, 18:20
RPRX Royalty Pharma plc 26 May 2022 2 -$4,029,091 4 EVP, Investments & GC 31 May 2022, 17:19
RPRX Royalty Pharma plc 23 May 2022 1 -$4,026,770 4 EVP, Investments & GC 25 May 2022, 17:10
RPRX Royalty Pharma plc 16 Nov 2021 5 -$10,596,693 4 EVP, Investments & GC 18 Nov 2021, 18:18
RPRX Royalty Pharma plc 26 Jul 2021 2 -$531,532 4 EVP, Investments & GC 27 Jul 2021, 17:29
RPRX Royalty Pharma plc 12 Jul 2021 3 -$972,456 4 EVP, Investments & GC 14 Jul 2021, 17:18
RPRX Royalty Pharma plc 06 Jul 2021 6 -$3,733,762 4 EVP, Investments & GC 08 Jul 2021, 19:36
RPRX Royalty Pharma plc 10 Jun 2021 3 -$3,254,369 4 EVP, Investments & GC 14 Jun 2021, 18:42
RPRX Royalty Pharma plc 04 Jun 2021 12 -$11,616,797 4 EVP, Investments & GC 08 Jun 2021, 20:12
RPRX Royalty Pharma plc 02 Jun 2021 2 -$2,632,512 4 EVP, Investments & GC 04 Jun 2021, 18:48
RPRX Royalty Pharma plc 07 May 2021 6 $0 4 EVP, Investments & GC 11 May 2021, 21:05